1. Shu XH, Li H, Sun XX, Wang Q, Sun Z, Wu ML, Chen XY, Li C, Kong QY, Liu J. Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. PLoS One. 2011;6:e27484.
2. Shu XH, Li H, Sun Z, Wu ML, Ma JX, Wang JM, Wang Q, Sun Y, Fu YS, Chen XY, Kong QY, Liu J.Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Biochem Pharmacol. 2010;79:1516-1525.
3. Shu XH, Li H, Sun Z, Ma JX, Sun Y,Wu ML, Fu YS, Yang Y, Zhang KL, Wang Q, Kong QY,Chen XY, Liu J.Resveratrol in human medulloblastoma cells: Metabolism and induction of differentiation and apoptosis. J Biotechnol. 2008,136s:179-180.
4. Sun Z, Li H, Shu XH, Shi H, Chen XY, Kong QY, Wu ML, Liu J. Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells. FEBS J. 2012;279:2381-2392.
5. Li CG, Li ML, Shu XH, Liu YJ, Wu WS. Antitumor effects of recombinant human interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis. Cancer Chemother Pharmacol. 2010;66:981-986.